Enhanced anti-tumor and anti-metastatic activity of quercetin using pH-sensitive Alginate@ZIF-8 nanocomposites: in vitro and in vivo study

被引:2
|
作者
Rostamkhani, Neda [1 ,2 ]
Salimi, Maryam [1 ,2 ]
Adibifar, Arghavan [1 ,2 ]
Karami, Zahra [2 ,3 ]
Agh-Atabay, Abdol-Hakim [4 ]
Rostamizadeh, Kobra [1 ,5 ]
Abdi, Zahra [6 ]
机构
[1] Zanjan Univ Med Sci, Sch Pharm, Dept Pharmaceut Biomat, Zanjan, Iran
[2] Zanjan Univ Med Sci, Pharmaceut Nanotechnol Res Ctr, Zanjan, Iran
[3] Zanjan Univ Med Sci, Sch Pharm, Dept Pharmaceut Nanotechnol, Zanjan, Iran
[4] Bahar Clin & pathol Lab, Zanjan, Iran
[5] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Dept Pharmacol, Seattle, WA 98195 USA
[6] Zanjan Univ Med Sci, Sch Med, Dept Anat Sci, Zanjan, Iran
关键词
zeolitic imidazolate frameworks; quercetin; alginate; pH-sensitive drug delivery; breast cancer; ZEOLITIC IMIDAZOLATE FRAMEWORKS; METAL-ORGANIC FRAMEWORK; DRUG-DELIVERY; PHYSICOCHEMICAL PROPERTIES; THERMAL-STABILITY; HYALURONIC-ACID; NANOPARTICLES; ZIF-8; ALGINATE; RELEASE;
D O I
10.1088/1361-6528/ad713f
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Quercetin (Qc) possesses anti-cancer properties, such as cell signaling, growth suppression, pro-apoptotic, anti-proliferative, and antioxidant effects. In this study, we developed an alginate-modified ZIF-8 (Alg@ZIF-8) to enhance the anti-tumor efficacy of Qc. The developed alginate-modified quercetin-loaded ZIF-8 (Alg@Qc@ZIF-8) was characterized using scanning electron microscope (SEM), dynamic light scattering (DLS), fourier transform infrared spectroscopy Thermogravimetric analysis, Brunauer-Emmett-Teller, and x-ray diffraction. The drug release pattern was evaluated at pH 5.4 and 7.4. The cytotoxicity of nanoparticles was assessed on the 4T1 cell line. Finally, the anti-tumor activity of Alg@Qc@ZIF-8 was evaluated in 4T1 tumor-bearing mice. SEM showed that the nanoparticles were spherical with a diameter of mainly below 50 nm. The DLS showed that the developed nanoparticles' hydrodynamic diameter, zeta potential, and polydispersity index were 154.9 +/- 7.25 nm, -23.8 +/- 5.33 mV, and 0.381 +/- 0.09, respectively. The drug loading capacity was 10.40 +/- 0.02%. Alg@Qc@ZIF-8 exhibited pH sensitivity, releasing more Qc at pH 5.4 (about 3.62 times) than at pH 7.4 after 24 h. Furthermore, the IC50 value of Alg@Qc@ZIF-8 on the 4T1 cell line was 2.16 times lower than net Qc. Importantly, in tumor-bearing mice, Alg@Qc@ZIF-8 demonstrated enhanced inhibitory effects on tumor growth and lung metastasis compared to net Qc. Considering the in vitro and in vivo outcomes, Alg@Qc@ZIF-8 might hold great potential for effective breast cancer management.
引用
收藏
页数:17
相关论文
共 36 条
  • [11] Novel pH-sensitive triptolide-loaded micelles: a potential approach to increase anti-tumor activity of the diterpenoid epoxide
    Lu, Zhimeng
    Yan, Kun
    Liu, Chunlei
    Wang, Jiapeng
    Yu, Guiping
    Zhang, Hao
    JOURNAL OF NANOPARTICLE RESEARCH, 2024, 26 (04)
  • [12] Novel pH-sensitive triptolide-loaded micelles: a potential approach to increase anti-tumor activity of the diterpenoid epoxide
    Zhimeng Lu
    Kun Yan
    Chunlei Liu
    Jiapeng Wang
    Guiping Yu
    Hao Zhang
    Journal of Nanoparticle Research, 2024, 26
  • [13] Co-delivery of Metformin and Paclitaxel Via Folate-Modified pH-Sensitive Micelles for Enhanced Anti-tumor Efficacy
    Yu Xiao
    Shuang Wang
    Qingyu Zong
    Zongning Yin
    AAPS PharmSciTech, 2018, 19 : 2395 - 2406
  • [14] pH-sensitive and tumor-targeting nanogels based on ortho ester-modified PEG for improving the in vivo anti-tumor efficiency of doxorubicin
    Wang, Xin
    Zheng, Yan
    Xue, Yanbing
    Wu, Yu
    Liu, Yongfeng
    Cheng, Xu
    Tang, Rupei
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2021, 207
  • [15] Co-delivery of Metformin and Paclitaxel Via Folate-Modified pH-Sensitive Micelles for Enhanced Anti-tumor Efficacy
    Xiao, Yu
    Wang, Shuang
    Zong, Qingyu
    Yin, Zongning
    AAPS PHARMSCITECH, 2018, 19 (05): : 2395 - 2406
  • [16] Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity
    Zhao, Yang
    Ren, Wei
    Zhong, Ting
    Zhang, Shuang
    Huang, Dan
    Guo, Yang
    Yao, Xin
    Wang, Chao
    Zhang, Wei-Qiang
    Zhang, Xuan
    Zhang, Qiang
    JOURNAL OF CONTROLLED RELEASE, 2016, 222 : 56 - 66
  • [17] Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling
    Sivak, Ladislav
    Subr, Vladimir
    Kovarova, Jirina
    Dvorakova, Barbora
    Sirova, Milada
    Sihova, Blanka
    Randarova, Eva
    Kraus, Michal
    Tomala, Jakub
    Studenovsky, Martin
    Vondrackova, Michaela
    Sedlacek, Radislav
    Makovicky, Petr
    Fucikova, Jitka
    Vosahlikova, Sarka
    Spisek, Radek
    Kostka, Libor
    Etrych, Tomas
    Kovar, Marek
    JOURNAL OF CONTROLLED RELEASE, 2021, 332 : 563 - 580
  • [18] Synthesis of the pH-sensitive nanoparticles based on the acylhydrazone bonds conjugated doxorubicin and studies on their in vivo anti-tumor effects (vol 260, 115715, 2023)
    Shi, Yongli
    Xu, Suyue
    Zhu, Huiqing
    Zhao, Bingqian
    Sun, Zeyu
    Dong, Ruoyi
    Li, Na
    Hou, Xueyan
    Yang, Xue
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 262
  • [19] Enhanced in vitro and in vivo anti-tumor activity of bortezomib (Velcadeo®, PS-341) when administered with interferon-alpha
    Lesinski, GB
    Shah, NN
    Raig, E
    Hade, E
    Brown, L
    Lewis, A
    Go, MR
    Bouchard, P
    Carson, WE
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 622 - 623
  • [20] MPT0B292 enhances acetylation of α-tubulin through up-regulation of acetyltransferase gene, MEC-17 and exhibits potent anti-tumor, anti-angiogenesis and anti-metastatic effects in vitro and in vivo
    Chang, Jang-Yang
    Cheng, Yun-Ching
    CANCER RESEARCH, 2015, 75